Nuclear BCL9 was significantly higher in both the IDC and DCIS regions of DCIS-IDC samples compared to either pure DCIS or adjacent normal tissue (Supplementary Fig. 1g). This evidence concerns the gene BCL9 and ductal breast carcinoma in situ.